Concordance of Three Imaging Methods by Dynamic CT, Contrast Ultrasound and CT Angiography in the Characterization of Endoleaks in Patients With an Aortic Endoprosthesis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

Among patients who have undergone EVAR, there is a significant risk of 20-50% endoleak. These endoleaks often require secondary interventions to reduce the risk of expansion or rupture. Currently, three-phase CT angiography and CEUS ultrasound are recommended in the post-operative monitoring of EVAR but these remain limited in characterizing the type and source of endoleak. In this study the investigators will study the interest of d-CTA for a better detection and characterization of endoleaks.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients 18 years of age and older,

Patients who have received EVAR ,

Detection of endoleak and/or with an aneurysmal sac enlargement greater than or equal to 5 mm over 6 months.

Disqualifiers

Minor patients,

absence of endoleak and growth of the aneurysmal sac (greater than or equal to 5 mm over 6 months),

patient under guardianship, curators, safeguard of justice,

patient deprived of liberty,

Trial design

Design model

Single group

Treatments tested in this trial

  • three-phase CT angiography

    Other intervention

    three-phase CT angiography

  • CEUS ultrasound

    Other intervention

    CEUS ultrasound

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Endoleak classification using the CT angiography

Endoleak classification using the CT angiography

Time frame
5 years
2

Variation of Endoleak classification between CEUS ultrasound and the CT angiography

Variation of Endoleak classification between CEUS ultrasound and the CT angiography

Time frame
5 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.